- Original article
- Open Access
Study of addiction in newly diagnosed patients with pulmonary tuberculosis in Abbasia Chest Hospital
Egyptian Journal of Bronchology volume 12, pages 105–113 (2018)
Drug abuse is an important factor in the epidemiology of tuberculosis (TB) in developing and developed countries, and there is a triple relationship between pulmonary TB, HIV, and drug users.
The aim of this work was to study the relation between addiction and newly diagnosed patients with pulmonary TB from Abbasia Chest Hospital’s outpatient clinic or admitted to the departments or ICU during the 8 months from August 2015 to April 2016.
Patients and methods
This prospective study was conducted on 100 addict male patients who were diagnosed as having new cases of pulmonary TB (positive sputum for ZN stain) at Chest Departments and respiratory ICU in Abbasia Chest Hospital during the 8 months from August 2015 to April 2016 to detect the relation between addiction and TB by full history, laboratory investigations, and chest radiography.
Most of the cases were taking a combination of drugs and more of cannabis, except for dead cases, where intravenous heroin was the top drug abused with longer duration of addiction. Cavitary and infiltrative patterns were present in more than half of the cases, with being more infiltrative among dead cases, with grade III severity in the chest radiography taking the upper hand. A minority of the cases had pleural effusion, pneumothorax and lung abscess.
Drug abusers are at high risk of TB infection and disease, and intravenous drug abuse is considered an important factor in HIV-associated TB.
Drug addiction is a major public health problem that needs to be studied from different aspects.
World Health Organization. Global tuberculosis report (WHO). Geneva, Switzerland: World Health Organization; 2013.
Rudeeaneksin J, Bunchoo S, Srisungngam S, Sawanpanyalert P, Chamnangrom S, Kamolwat A, et al. Rapid identification of Mycobacterium tuberculosis in BACTEC MGIT960 cultures by in-house loop-medicated isothermal amplification. Jpn J Infect Dis 2012; 65:306–311.
World Health Organization. WHO: global tuberculosis control: surveillance, planning, financing. WHO report 2008. WHO/HTM/TB/ 2008. 3 93. Geneva, Switzerland: WHO; 2008. pp. 1–294.
WHO. Global tuberculosis control. Geneva, Switzerland: World Health Organization; 2011.
Dhingra VK, Lall D, Aggarwal N, Vashist RP. DOTS in drug addicts with TB: Delhi experience. Indian J Tuberc 2005; 55:122–126.
Friedman H, Newton C, Klein TW. Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev 2003; 16:209.
Abalkhail BA. Social status, health status and therapy response in heroin addicts. East Mediterr Health J 2001; 7:465–472.
Robert GD, Timothy CR, Richard SG. Oxford Journals, Clinical Infectious Diseases, Volume 48, Issue 1, pp. 72–82. WHO Website. Accessed May 21, 2009; World Health Organization. Programs and project for Tuberculosis. The Stop TB Strategy.
Niveau G. Prevention of infectious disease transmission in correctional settings: a review. Public Health 2006; 120:33–41.
Nguyen LT, Picard-Bernard V, Perriot J. Legionnaires’ disease in cannabis smokers. Chest 2010; 138:989–991.
Oeltmann JE, Oren E, Haddad MB. Tuberculosis outbreak in marijuana users, Seattle, Washington, 2004. Emerg Infect Dis 2006; 12:1156–1569.
American Psychiatric Association, American Academy of Pain Medicine, the American Pain Society, the American Society of Addiction Medicine. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
WHO. Tuberculosis, fact sheet no. 104. 2016. Available at: http://www.who.int/mediacentre/factsheets/fs104/en/
National Institute on Drug Abuse. Drug facts: understanding drug abuse and addiction. 2012. Available at: https://www.drugabuse.gov/publications/drugfacts/understanding-drug-abuse-addiction#references
Sharma SK, Mohan A. Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest 2006; 130:261–272.
Lamptey JJ. Socio-demographic characteristics of substance abusers admitted to a Private Specialist Clinic. Ghana med J 2005; 39:2–7.
Tai M. Acute heroin intoxication in heroin related victims. Ann Intern Med 1996; 3:5–11.
Filho OF, Turchi MD, Laranjeriras R, Castelo A. Epidemiological profile of tuberculosis infection and disease among cocaine users admitted to hospitals of greater Sao Paulo city. J Pneumologia 2003; 29:125–132.
Melo FAF. Transmission of tuberculosis. Bol Pneumol Sanit 1997; 5:76–77.
Kornreich C, Delle-Vigne D, Campanella S, Noël X, Papageorgiou C, Brown O. Conditional reasoning difficulties in polysubstance-dependent patients. Psychol Addict Behavi 2012; 26:665–671.
Wang W, Xiao H, Lu L. Case-control retrospective study of pulmonary tuberculosis in heroin-abusing patients in China. J Psychoactive Drugs 2006; 38:203–205.
Imtiaz A, Muhammad A, Muhammad S. Association between drug dependence and anemia in Pakistani patients. APMC 2007; 1:2–15.
Saad T, Tirkey AS. Association between pulmonary tuberculosis and smoking: a case-control study. Indian J Community Health 2013; 25:342.
Yusuph H, Zailani SB, Ahidjo A. Prevalence of HIV infection in tuberculosis patients in Nguru, Northeastern Nigeria. Sahel Medical J 2005; 8:65–67.
Quan VM, Aramrattana A, Vongchak T, Latkin C, Donnell D, Liu T, et al. Mortality among injection drug users in northern Thailand: a prospective cohort study. J Addict Med 2010; 4:217–222.
Sanchez-Carbonell X, Vilaregut A. A 10-year follow-up study on the health status of heroin addicts based on official registers. Addiction 2001; 96: 1777–1786.
Alavi SM, Bakhtiarinia P, Eghtesad M, Albaji A, Salmanzadeh S. Acomparative study on the prevalence and risk factors of tuberculosisamong the prisoners in Khuzestan, South-West Iran. Jundishapur J Microbiol 2014; 7:e18872.
Drobniewski G, Balanova Y, Ruddy M, Graham C, Kunetzov S, Gusarova G, et al. Tuberculosis, HIV seroprevalence and intravenous drug abuse in prisoners. Eur Respir J 2005; 26:298–304.
Alavi SM, Salami N. The causes of death among patients with tubersulosis in Khuzestan, Iran. Pak J Med Sci 2008; 24(Pt I):217–220.
Kuba M, Nakasone K, Miyagi S, Kyan K, Shinzato T, Kohagura N, et al. Clinical evaluation on causes of death in patients with active pulmonary tuberculosis. Kekkaku 1996; 71:293–301.
Kourbatova EV, Borodulin BE, Borodulina EA, del Rio C,Blumberg HM, Leonard MK Jr. Risk factors for mortality among adult patients with newly diagnosed tuberculosis in Samara, Russia. Int J Tuberc Lung Dis 2006; 10:1224–1230.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms.
About this article
Cite this article
Saeed, A.M., Raafat, R.H. & Elbaz, E.M. Study of addiction in newly diagnosed patients with pulmonary tuberculosis in Abbasia Chest Hospital. Egypt J Bronchol 12, 105–113 (2018). https://doi.org/10.4103/ejb.ejb_115_17
- pulmonary tuberculosis